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Abstract 
Evidence from epidemiological studies suggest that low levels of vitamin D 
during early life alter brain development and may increase the risk of various 
adverse health outcomes, including schizophrenia. The aim of this experiment 
was to examine the effect of developmental vitamin D (DVD) deficiency on 
attentional processing using the 5-choice serial reaction time task (5C-SRT) 
and the 5-choice continuous performance test (5C-CPT), which specifically 
assesses sustained attention and vigilance in rodents. DVD-deficient and 
control rats were exposed to a series of target and non-target trials within 
each operant testing session. A number of measures were recorded including 
hit, miss, false alarm and correct rejection, as well as premature and 
perseverative responses. Performance on 5C-CPT was also assessed after 
administration of the atypical antipsychotic, clozapine. The adult offspring of 
DVD-deficient rats had higher levels of impulsivity, as demonstrated by a 
significant increase in premature responses. On the 5C-SRT and target trials 
of the 5C-CPT, accuracy was not significantly affected by prenatal diet; 
however DVD-deficient rats made 50% fewer correct rejections compared to 
controls on non-target trials of the 5C-CPT. Thus, control rats were able to 
discriminate between target and non-target trials, whereas DVD-deficient rats 
were unable to make this discrimination. Clozapine reduced the occurrence of 
false alarms in DVD-deficient rats to a level comparable to control values. 
Taken together these data suggest DVD-deficient rats have increased 
impulsivity as well as a lack of inhibitory control, and these features may be 
informative in terms of modeling the cognitive deficits observed in 
schizophrenia. 
INTRODUCTION 
Schizophrenia is a poorly understood but very disabling group of brain 
disorders affecting approximately 1% of the population [1]. While 
hallucinations and delusions (positive symptoms) feature prominently in 
diagnostic criteria, impairments on memory and attentional processing 
(cognitive symptoms) are attracting increasing interest in modern 
neuropsychiatry [2]. For example, data from prospective birth cohorts have 
shown consistent evidence that cohort members who develop schizophrenia 
as adults tend to have deficits in a range of premorbid intellectual impairments 
covering verbal, non-verbal and mathematical abilities and attentional, 
executive and motor impairments [3]. With respect to clinical outcomes, 
compared to positive symptoms, neurocognitive measures have been 
repeatedly found to have greater predictive value with respect to social and 
occupational recovery [4,5].  
 
Based on clues from epidemiology, we have proposed that low prenatal 
vitamin D may be a risk factor for later development of schizophrenia [6]. 
Many studies have shown that those born in winter and spring have a 
significantly increased risk of developing schizophrenia [7], and that those 
born at higher latitudes are also at increased risk [8], with both the incidence 
and prevalence of schizophrenia being significantly greater at higher latitudes 
[9]. In a recent case-control study we have shown that low prenatal vitamin D 
is a plausible candidate risk factor for this disease, because those with low 
levels of vitamin D at birth had a two-fold increase in the risk of developing 
schizophrenia in later life [10]. 
 Prenatal vitamin D deficiency has been shown to alter brain development and 
adult behaviour in rodents [11,12], in which the foetus develops in utero in a 
vitamin D-deficient but normocalcaemic dam. For example, developmental 
vitamin D (DVD) -deficient neonates had larger lateral ventricles, increased 
cell proliferation and reduced apoptosis [13] as well as altered dopamine 
ontogeny [14] and signaling [15]. Adult DVD-deficient animals had larger 
lateral ventricles compared to controls [16], as well as significant changes in 
protein and gene expression in the brain [17]. Behaviourally we have shown 
that DVD-deficient adults have a transient “hyperlocomotion” compared to 
controls [18-20] and they have impaired responses on tasks assessing latent 
inhibition [21]. Finally, DVD-deficient rats have enhanced locomotion in 
response to the NMDA antagonist MK-801 [22], a behaviour which is blocked 
by the antipsychotic, haloperidol [20].  
 
The assessment of cognitive deficits in patients with schizophrenia can 
include a bewildering array of potential measures. Similarly, the assessment 
of attention, learning and memory in rodent models could follow many 
different directions [23]. The prominent test of attentional processing in 
rodents is the 5-choice serial reaction task (5C-SRT), which incorporates 
measures of impulsivity and perseverance [23,24]. Schizophrenia patients 
have repeatedly been shown to perform worse than controls on the 
continuous performance test (CPT) [25]. In alignment with the human CPT, 
the addition of a withhold condition has recently been incorporated into rodent 
testing resulting in the 5-choice continuous performance test (5C-CPT) [26]. 
Building on the 5C-SRT, response inhibition and vigilance can now also be 
assessed. Response measures used in signal detection theory such as hit, 
miss, false alarm and correct rejection can now be measured in rodents, 
creating a test that more closely mirrors the human CPT [26]. 
 
Based on the most robust findings in schizophrenia [27], and recommendation 
of the panel for the Measurement And Treatment Research for Improving 
Cognitive Symptoms in Schizophrenia (MATRICS) [28,29], the focus of the 
current study was to investigate cognitive functioning in the DVD-deficient rat. 
The DVD-deficient rat model is based on evidence from disease epidemiology 
and displays good face validity as a developmental animal model of 
schizophrenia. This study aimed to assess cognitive deficits in the DVD-
deficient rat on the 5C-SRT and 5C-CPT, before investigating the effects of 
the atypical antipsychotic clozapine on performance. Antipsychotics generally 
have significant negative side effects and poor efficacy in the treatment of 
cognitive symptoms, however selective improvements in function have been 
reported in patients and animal models [30,31]. 
 
MATERIALS AND METHODS 
 
Animals and Housing 
All procedures were performed with approval from the Queensland University 
Animal Ethics Committee, under the guidelines of the National Health and 
Medical Research Council of Australia. Sprague-Dawley rats (Herston Animal 
Facility, QLD, Australia) were housed in same-sex pairs in Macrolon cages 
with Sanichip bedding and wire lids at a stable temperature of 21 ± 1 °C. For 
the 5C-SRT and 5C-CPT experiments, 16 DVD-deficient (n = 8 females, n = 8 
males) and 12 control rats (n = 6 females, n = 6 males) were used from 20 
weeks of age. Rats were reared, housed and tested at The University of 
Queensland and, prior to testing, had free access to food and water.  
Vitamin D deficient and control offspring were generated as previously 
described [32]. Briefly, female Sprague-Dawley rats were kept on a vitamin D 
deficient diet (Vitamin D Deficiency AIN93G Rodent diet, Dyets Inc., 
Bethlehem, PA, USA). Animals were housed on a 12h light/dark cycle (lights 
on at 0600 h) using incandescent lighting, to avoid ultraviolet radiation within 
the vitamin D action spectrum. These conditions were maintained for six 
weeks prior to mating and throughout gestation. Control animals were kept 
under similar conditions except they received a vitamin D replete diet 
(Standard AIN93G Rodent diet, Dyets Inc., Bethlehem, PA, USA). At birth 
vitamin D deplete dams (and corresponding litters) were given a vitamin D 
replete diet and all rats were kept under the same conditions for the 
remainder of the experiment. At weaning (postnatal day 21) all animals were 
housed in same sex groups of 2 and kept on standard food (Feeder and 
Grower diet, Specialty Feeds, WA) until behavioural testing. Rats were placed 
on a restricted feeding schedule to decrease body weight to 90% of their 
original free-feeding weight and remained food restricted throughout training 
and testing. Rats had ad libitum access to water in their home cage.  
 
Testing Apparatus  
Training and testing took place in eight 5-hole operant chambers 
(50x50x50cm, Med Associates Inc., St. Albans, VT, USA) situated in a room 
under dim red light. The chamber was housed in a ventilated, sound 
attenuated box and ventilated by a fan with background noise of 70dB 
presented from a speaker within the chamber. The rats were trained to 
respond to brief pulses of light (6.4 mm diameter yellow LED) within one of 
five equally spaced apertures (2.5 x 2.5 x 2.2 cm) situated within a curved 
aluminum wall. A nose poke into the aperture broke an infrared beam and this 
would result in delivery of a 45 mg food pellet (F0021, dustless precision 
pellet, Bioserv, Frenchtown, NJ, USA) to a food magazine located opposite to 
the 5-hole wall. The food magazine was fitted with a light (10 mm diameter 
white bulb) and head entries to the magazine were recorded using an infrared 
beam. A house light was located on the ceiling directly above the food 
magazine. The control of stimuli and recording of responses were managed 
by two SmartCtrl Packages 8-In/16-Out with additional interfacing by MED-PC 
for Windows (Med Associates Inc., St. Albans, VT, USA).  
 
5C-SRT 
Rats were trained to perform the 5-choice serial reaction task (5C-SRT) as 
described previously [33], with each session lasting 30 min or 100 trials, 
whichever was completed first. Briefly, rats were trained to detect a stimulus 
light in one of the 5 aperture locations with various parameters adjusted 
across training sessions including: duration of the stimulus light (30, 20, 10, 5. 
2.5, 1.25, 1 s), limited hold period (30, 20, 10, 5 s) and reward duration (10, 5, 
2 s), with a fixed inter-trial interval (ITI) of 5 s. We recorded correct and 
incorrect responses within the limited hold time. Rats were given a 5 s time-
out, when the house light came on, for an incorrect response, omission error 
or premature response. Repeated nose pokes to any aperture after the initial 
response was recorded as a perseverative response, which did not affect the 
duration of the time out. During the final phase of training the trials were 
separated by a variable ITI (3, 4, 5, 6, 7 s). Rats were considered to have 
acquired the task when they made greater than 60 correct responses and 
fewer than 20 errors of omission over 3 consecutive days. Upon reaching 
criteria, rats were challenged over 3 days by varying the stimulus duration 
(0.25, 0.5, 1, 1.25 s) within each session followed by 3 days on a schedule 
with multiple inter-trial intervals (1, 3, 5, 7 s). Performance measures included 
accuracy (correct/ correct + incorrect), number of premature responses, 
number of omissions, number of perseverative responses, latency to a correct 
response and latency to collect reward. 
 
 
5C-CPT 
Once a stable level of performance on the 5C-SRT was obtained, the rats 
were tested over fourteen days on the 5-choice continuous performance task 
(5C-CPT). This protocol consisted of 80 target and 40 non-target trials (total of 
120 trials) per session [adapted from [26]]. The target trials were similar to 
those used during 5C-SRT with the following parameters; 1 s duration of the 
stimulus light, 5 s limited hold, a variable ITI (3, 4, 5, 6, 7 s), 5 s reward 
duration, and a 5 s time-out. During target trials responses were recorded as 
either a hit (correct response) or a miss (incorrect response + error of 
omission). During the non-target trials the stimulus light appeared in all 5 
apertures for 1 s and a response in any aperture resulted in a 5 s time out, 
during which the house light came on and was recorded as a false alarm 
(FA). Successful inhibition of a response during the 3-s limited hold resulted in 
a correct rejection (CR) and the delivery of a food pellet in the illuminated 
magazine. The non-target trials were pseudo-randomly interspersed within the 
80 target trials, with a maximum of 3 sequential non-target trials. Response in 
any aperture during the ITI was recorded as a premature response and 
resulted in a 5 s time out. 
 
In addition, the mean correct latency, mean premature latency, mean false 
alarm latency and percent omissions were recorded. The following 
parameters were also calculated, as described previously [26], hit rate, p(Hit) 
as the proportion of target trials correctly detected; false alarm rate, p(FA), as 
the proportion of non-target trials with an incorrect response; sensitivity index, 
SI, as a non-parametric measure of the ability to discriminate between target 
and non-target trials; and responsivity index, RI, as a non-parametric measure 
of response bias, and these are outlined in Table 1. 
 
Treatment with Clozapine 
DVD-deficient and control rats were then randomly divided to receive either 
an acute injection (i.p.) of either saline or clozapine (2.5 mg/kg, pH = 7.4, 
Sigma-Aldridge, St. Louis, MO) 1 h prior to testing on a single 5C-CPT 
session. This dose was carefully selected based on previous experiments 
[31,34-36]. 
 Statistical Analyses 
All data were analysed using the SPSS software package (ver. 17, SPSS Inc. 
IL, USA). Data obtained for the 5C-SRT and 5C-CPT were subjected to a 
repeated measures analysis of variance (ANOVA), with Maternal Diet as a 
between subjects factor and day as a within subjects factor. Significant 
differences were followed up with planned post-hoc bonferroni tests. 
Significance was set at p < 0.05. No significant interactions of Sex x Maternal 
Diet were observed and so all data were pooled for sex. 
 
RESULTS 
5C-SRT 
DVD-deficient rats required more trials (21.5  1.44) to reach criteria for level 
7 (stimulus duration = 1 s) compared to controls (17.9  1.34), although this 
difference did not reach significance (F1,26 = 3.16, P = 0.087). On the 3-day 
multiple stimulus durations level, rats were challenged to respond to a range 
of stimulus durations (0.2 – 1.0 s, Table 2). There was no significant effect of 
Maternal Diet on any measure of performance in the multiple stimulus 
durations task, including accuracy, omission rate, premature responses or 
perseverative responses (P > 0.05). At low stimulus durations, all rats made 
more omissions (F3,78 = 11.81, P < 0.001) and were less accurate when 
responding (F3,78 = 127.56, P < 0.001). On the 3-day multiple inter-trial 
intervals level (Table 3), there was no significant effect of Maternal Diet on 
performance over various inter-trial intervals on measures such as accuracy, 
omission rate, premature responses or perseverative responses (P > 0.05). 
Over the different inter-trial intervals, the omission rate was fairly stable, 
except for an increase in omissions in trials after an inter-trial interval of 1.0 s, 
(Effect of inter-trial interval F3,78 = 83.471, P < 0.001).  
 
 
 
5C-CPT 
Over the 14-session 5C-CPT, DVD-deficient rats had similar levels of 
performance to controls on the primary measure of performance in target 
trials; p(Hit) (Fig. 1a). However, there was a significant effect of Maternal diet 
on the primary measure of performance in non-target trials; p(FA) (F1,26 = 
18.05.73, P < 0.001; Fig. 1b), and this was seen on the first session and 
persisted throughout all 14 5C-CPT sessions. With respect to signal detection 
DVD-deficient rats had significantly lower values for both  RI (F1,26 = 16.89, P 
< 0.001) and SI (F1,26 = 9.05, P < 0.01) compared with control rats (Fig. 1c,d), 
and DVD-deficient rats also made more premature responses than control 
rats (F1,26 = 4.25, P = 0.05, Fig. 1e). There was no significant effect of 
Maternal diet on accuracy (Fig. 1f), omission rate or perseverative responses 
during the 5C-CPT sessions. 
 
Treatment with Clozapine 
Acute treatment of DVD-deficient rats with clozapine reversed the deficits in 
p(FA), reward latency and premature responses (Table 4). There was no 
significant main effect of Maternal diet on any measure after clozapine 
treatment (P > 0.05). Overall, acute treatment with clozapine in control and 
DVD-deficient rats led to a significant increase in omissions and correct 
latency and a significant decrease in premature responses and p(Hit) (F1,26 > 
5.64, P < 0.025, for each comparison). 
 
Saline-treated DVD-deficient rats had similar scores for p(Hit) but there was a 
significant effect of Maternal diet on p(FA) (F1,26 = 18.10, P = 0.001, Fig. 2). 
DVD-deficient rats had a reduced reward latency (F1,26 = 5.09, P = 0.044) and 
made more premature responses than control rats, although this failed to 
reach significance (F1,26 = 3.15, P = 0.10). There was no significant effect of 
Maternal diet on omission rate, perseverative responses or correct latency 
after saline-treatment.  
 
DISCUSSION 
DVD-deficient rats demonstrated mildly enhanced impulsivity and while they 
were normal on all measures of vigilance on target trials, their lack of 
inhibition on non-target trials was observed immediately and persisted 
throughout testing. Controls showed a steady improvement in their ability to 
withhold responding over the 14 sessions of 5C-CPT testing; confirming 
Sprague-Dawley rats are capable of discriminating between target and non-
target conditions. Maternal vitamin D deficiency decreased reward latency; 
suggesting motivational aspects of the task were also subtly altered. There 
was no effect of maternal diet detected under schedules of variable stimulus 
duration or inter-trial interval, indicating comparable stimulus discrimination 
and ability to attend when stimulus onset was unpredictable.  
While premature responses on target trials did not differ between groups on 
the 5C-SRT, under the additional load of the 5C-CPT, DVD-deficient rats 
showed poorer inhibition of this erroneous behaviour. Interestingly, acute 
administration of clozapine resulted in reversal of these deficits in DVD-
deficient rats.  
 
The importance of extending the basic 5C-SRT to include the more 
challenging 5C-CPT component in animal studies is evident. Deficits were 
clearly and persistently detected once inhibitory demands were increased with 
the inclusion of non-target trials. The 5C-CPT protocol was designed to 
measure vigilance in mice and includes parameters of signal detection theory 
used during CPT testing in humans [26]. While the 5C-CPT protocol is a 
relatively new tool in cognitive testing, preliminary application to assess 
deficits associated with schizophrenia has found a reduction in behavioural 
inhibition in rats treated sub-chronically with PCP [37]. PCP administration 
has been used in a number of studies to model positive, negative and 
cognitive symptoms of schizophrenia [38-42]. These similarities suggest that 
the DVD deficiency rat model shares a cognitive deficit that has also been 
observed in another animal model of schizophrenia. Evidence that 
schizophrenic patients and first-degree relatives perform poorly on the human 
CPT strengthens the relevance of this tool to assess cognition. 
 
Another behavioural change that only became apparent upon 5C-CPT testing 
was a significant decrease in the time taken for reward collection in DVD-
deficient rats. Latency to reward collection was not found to differ in the 5C-
SRT, therefore it is unlikely that substantial motivational differences exist 
between control and DVD-deficient rats. However, the additional attentional 
load of the 5C-CPT appears to have altered motivational, impulsive and 
inhibitory behaviours. Given the relevance of motivational changes to 
schizophrenia, this alteration should be assessed separately under conditions 
designed to specifically measure motivation. The ability to assess and 
discriminate changes in complex cognitive behaviours is critical for modeling 
endophenotypes of mental disorders. Given the sensitivity of continuous 
performance tasks to detect differences in schizophrenia patients and rodent 
models, this protocol may be beneficial in the search for pro-cognitive 
therapeutics. The strongest predictive measure of favourable outcomes for 
schizophrenic patients have been found within neurocognitive domains and 
yet cognitive symptoms remain largely untreated by antipsychotic medications 
[5]. In light of this issue, further validation of the 5C-CPT to detect cognitive 
deficits in other animal models of schizophrenia and the effectiveness of novel 
drugs to reverse deficits is warranted. 
 
Antipsychotic administration in this study found that acute clozapine treatment 
reduced false alarm responding in DVD-deficient rats. To the best of our 
knowledge, this is the first use of antipsychotics on the 5C-CPT. However, 
there have been numerous studies performed using antipsychotics in the 5C-
SRT. In an animal model relevant to schizophrenia, deficits induced by PCP 
treatment were partially reversed by clozapine [31]. Repeated PCP injections 
were shown to decrease accuracy as well as increasing premature and 
timeout responding [31]. Chronic clozapine was able to improve accuracy and 
reduce premature responding in these animals, while chronic clozapine alone 
did not alter accuracy or premature responding. This suggests clozapine is 
specifically acting to reverse PCP-induced attentional and inhibitory deficits. It 
is important to note that clozapine was only tested after acute administration 
in this study, however chronic use is required to provide relief to patients. It 
would be valuable to know if chronic administration could improve 
performance in a more stable manner, resulting in deficit reversal without drug 
administration immediately prior to testing. Although the current data are 
consistent with the finding that clozapine improves functioning in patients on 
attentional tasks [43], given the poor tolerability of clozapine in many patients, 
other compounds are needed to remediate cognitive deficits. 
 
The action of clozapine is complex, interacting with a number of different 
receptor types including dopamine, serotonin and acetylcholine [44]. 
Clozapine has some affinity for the D2 receptor, however in the PFC 
clozapine has a higher affinity for 5-HT2a than for D2 receptors. The PFC is 
central to information processing, particularly when the correct response is not 
obvious and a decision between conflicting behaviours is required. Previous 
studies using the 5C-SRT have found that 5-HT2a blockade in the mPFC 
results in improvements in accuracy and anticipatory responses [45]. Within 
the PFC, inhibitory control of impulsivity may be selectively influenced by 
serotonin while perseverative responding may be guided by dopamine 
receptor systems [36]. These findings suggest a mode of action for clozapine 
in restoring the proportion of false alarms in DVD-deficient rats to control 
levels. It is also important to note that while omissions increased for both 
control and DVD-deficient rats after clozapine, there was no effect of maternal 
diet indicating the improvement in inhibitory behaviour was not simply due to 
reduced responding. 
 
This study has shown that the 5C-CPT is a useful tool in discriminating subtle 
differences, which may not be detected under less strenuous testing. Further 
validation of the use of antipsychotics, particularly clozapine, comparing acute 
and chronic administration to reverse inhibitory deficits on the 5C-CPT would 
also be encouraged. The DVD-deficient rat model is characterised by a 
phenotype reminiscent of both positive and negative symptoms of 
schizophrenia, and these results suggest that DVD-deficient rats also have 
specific impairments in cognitive function. 
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 Figure Legends 
 
 
 
Fig. 1 Performance of control () and DVD-deficient rats () rats on the 5C-
CPT. All rats had normal performance to target stimuli as measured by the 
probability of hit rate (a). DVD-deficient rats had increased probability of false 
alarm responding to non-signal stimuli (b) and they showed poorer vigilance 
as measured by the sensitivity index (SI, c), and a lower responsivity index 
(RI, d). Although DVD-deficient rats made more premature responses overall, 
compared to controls, this response was not stable. All rats maintained high 
levels of accuracy (f) throughout testing. Data presented as mean  s.e.m.  
* P < 0.05, over all 14 sessions, repeated measures ANOVA. 
 
 
Fig. 2 Performance of control () and DVD-deficient () rats on the 5C-CPT 
after treatment with clozapine, saline or at baseline. All rats had normal 
performance to target stimuli as measured by the probability of hit rate (a). 
DVD-deficient rats had increased probability of false alarm responding to non-
signal stimuli at baseline and after saline treatment, but this was reduced by 
clozapine (b). DVD-deficient rats showed poorer vigilance as measured by the 
sensitivity index (SI, c), and a lower responsivity index (RI, d) at baseline and 
this effect was altered by clozapine. Saline treatment did not alter the SI but 
there was a significant reduction in RI from both control and DVD-deficient 
rats. Data presented as mean  s.e.m. * P < 0.05. 
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Table 1 Descriptions of the dependent variables used for the analysis of the 5C-SRT and  
              5C-CPT and how they were calculated. 
Measure (Target Trials)  
Accuracy (No. of correct responses) / (No. correct responses + no. incorrect responses) 
p(Hit): Probability of a hit response (No. of correct responses) / (Total no. of target trials) 
Omission Rate (No. of omissions) / (Total no. of target trials) 
Premature Responses No. of premature responses made 
Perseverative Responses A perseverative response occurred when a mouse nose-poked more than once in the correct hole 
Latency to Correct Response (s) Average time between target stimulus onset and correct nose poke 
Latency to Retrieve Reward (s) Average time between correct nose poke and reward retrieval 
Measure (Non-target Trials)  
p(FA): Probability of a false alarm response (No. of false alarm responses) / (Total no. of non-target trials) 
Perseverative False Alarm No. of perseverative false alarm responses made during non-target trials 
Latency to False Alarm (s) Average time between non-target stimulus onset and false alarm nose poke 
SI: Sensitivity Index 
RI: Responsivity Index 
[p(Hit)-p(FA)] / (2[p(Hit)+p(FA)]-[p(Hit)+p(FA)]2) 
[p(Hit)+p(FA)-1] / (1-[p(FA)-p(Hit)] 2) 
 
 
  
Table(s)
Table 2 Effects of DVD deficiency on 5C-SRT with a Shortened Stimulus Duration 
 
   Stimulus duration (s)   
Measure Group 0.25 0.5 1.0 1.25 
(A) Accuracy (%) CON 66.1 (2.1) 78.3 (2.1) 87.6 (2.3) 87.9 (1.6) 
 DVD 63.4 (2.1) 79.4 (2.0) 86.6 (1.6) 87.9 (1.5) 
      
(B) Premature (no.) CON 14.9 (3.3) 15.5 (4.8) 15.6 (2.8) 14.6 (2.0) 
 DVD 18.7 (2.8) 11.5 (1.8) 12.2 (2.2) 12.3 (1.5) 
      
(C) Omission (no.) CON 12.3 (1.1) 11.5 (1.5) 9.9 (1.0) 9.3 (1.4) 
 DVD 15.1 (1.8 ) 12.6 (1.6) 10.8 (0.9) 9.0 (1.0) 
      
(D) Perseverative (no.) CON 3.2 (0.6) 5.3 (1.4) 6.2 (1.1) 5.5 (1.1) 
 DVD 3.8 (0.8) 4.7 (0.9) 5.1 (0.8) 7.0 (1.4) 
      
(E) Correct latency (s) CON 0.57 (0.03) 0.62 (0.03) 0.66 (0.04) 0.65 (0.04) 
 DVD 0.49 (0.04) 0.53 (0.04) 0.57 (0.04) 0.64 (0.03) 
      
(F) Reward latency (s) CON 1.49 (0.08) 1.47 (0.08) 1.45 (0.08) 1.45 (0.07) 
 DVD 1.70 (0.06) 1.68 (0.06) 1.65 (0.06) 1.63 (0.06) 
 
After the rats had acquired the 5C-SRT they were tested with a range of stimulus durations 
(0.25, 0.5, 1.0 and 1.25 s). The table shows mean (+ SEM) percent accuracy (A), 
premature responses (B), percentage of omitted trials (C), number of perseverative 
responses (D), latency to respond on trials with a correct response (E), and latency to 
collect reward (F) in DVD-deficient and control rats. 
Table 3 Effects of DVD deficiency on 5C-SRT with Variable ITIs 
 
   ITI Length (s)   
Measure Group 1 3 5 7 
(A) Accuracy (%) CON 85.4 (2.9) 92.3 (1.4) 92.8 (1.2) 89.2 (1.1) 
 DVD 85.5 (2.9) 89.9 (1.2) 93.5 (0.8) 88.0 (1.2) 
      
(B) Premature (no.) CON 15.8 (2.3) 6.6 (1.3) 11.2 (1.9) 27.7 (3.6) 
 DVD 11.7 (1.8) 5.8 (1.0) 6.3 (0.8) 24.0 (3.3) 
      
(C) Omission (no.) CON 29.4 (3.7) 10.8 (1.6) 8.8 (1.5) 5.8 (0.8) 
 DVD 31.9 (4.0) 14.9(2.4) 8.6 (1.0) 7.6 (1.3) 
      
(D) Perseverative (no.) CON 5.9 (1.4) 6.7 (1.2) 5.3 (1.3) 3.9 (1.5) 
 DVD 7.2 (1.6) 6.8 (1.5) 5.5 (0.9) 4.1 (0.7) 
      
(E) Correct latency (s) CON 0.59 (0.05) 0.66 (0.02) 0.58 (0.03) 0.59 (0.03) 
 DVD 0.51 (0.05) 0.57 (0.03) 0.59 (0.03) 0.54 (0.03) 
      
(F) Reward latency (s) CON 0.80 (0.07) 1.21 (0.08) 1.22 (0.06) 1.21 (0.06) 
 DVD 0.88 (0.10) 1.22 (0.07) 1.39 (0.06) 1.31 (0.06) 
 
After the rats had acquired the 5C-SRT they were tested with a range of ITIs (1, 3, 5 and 7 
s). The table shows mean (+ SEM) percent accuracy (A), premature responses (B), 
percentage of omitted trials (C), number of perseverative responses (D), latency to 
respond on trials with a correct response (E), and latency to collect reward (F) in DVD-
deficient and control rats. 
Table 4 Effects of DVD deficiency on 5C-CPT under baseline conditions, or after treatment 
with saline or Clozapine 
 
Measure Group Baseline Saline Clozapine 
(A) Accuracy (%) CON 92.9 (1.6) 84.0 (4.1) 84.3 (7.9) 
 DVD 90.8 (0.6) 77.3 (2.8) 77.9 (5.7) 
     
(B) Premature (no.) CON 2.3 (0.5) * 4.8 (1.3) 3.0 (1.3) 
 DVD 4.5 (0.9)* 10.1 (2.4) 3.6 (1.6) 
     
(C) Omission (no.) CON 22.9 (4.0) 21.0 (4.9) 32.3 (5.4) 
 DVD 22.9 (2.3) 16.4 (4.3) 30.0 (5.0) 
     
(D) Perseverative (no.) CON 3.3 (0.9) 6.5 (2.4) 3.0 (0.7) 
 DVD 3.9 (0.7) 3.5 (1.1) 8.5 (3.2) 
     
(E) Correct latency (s) CON 0.83 (0.1) 0.78 (0.04) 0.89 (0.07) 
 DVD 0.74 (0.1) 0.70 (0.05) 0.92 (0.09) 
     
(F) Reward latency (s) CON 2.54 (0.23)* 2.76 (0.36)* 2.47 (0.21) 
 DVD 2.08 (0.07)* 1.97 (0.15)* 2.65 (0.25) 
 
 
The table shows mean (+ SEM) percent accuracy (A), premature responses (B), 
percentage of omitted trials (C), number of perseverative responses (D), latency to 
respond on trials with a correct response (E), and latency to collect reward (F), in DVD-
deficient and control rats. * p<0.05 compared to Control value.  
 
